Mr. SHRIYANSH SRIVASTAVA | Pharmacology | Young Scientist Award

Mr. SHRIYANSH SRIVASTAVA, Galgotias University , India 🎓

Professional Profile

🌱🎓Early Academic Pursuits

Shriyansh Srivastava embarked on his academic journey with a strong foundation in pharmaceutical sciences. He completed his Bachelor of Pharmacy from Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh, India, achieving a commendable 74.82%. His academic prowess continued as he pursued his Master of Pharmacy in Pharmacology at ISF College of Pharmacy, Moga, Punjab, where he maintained an impressive CGPA of 8.54.

👨‍🏫 Professional Endeavors

Currently serving as an Assistant Professor in the School of Medical and Allied Sciences, Department of Pharmacy at Galgotias University, Greater Noida, Uttar Pradesh, India, Shriyansh Srivastava brings his expertise to the forefront of pharmaceutical education. Since August 2021, he has been instrumental in shaping the minds of future pharmacists with a focus on the pharmaceutical field.

📚 Contributions and Research Focus

Shriyansh Srivastava’s research interests span pharmacology and clinical research, particularly focusing on innovative treatments and disease mechanisms. His Master’s thesis titled “Wnt β-Catenin antagonist pyrvinium prevents isoproterenol-induced cardiomyopathy by targeting ATP-sensitive K+ channel,” conducted under the guidance of Dr. Shamsher Singh and Dr. Gaaminepreet Singh at ISF College of Pharmacy, Moga, Punjab, showcases his dedication to advancing pharmaceutical knowledge.

🏆 Accolades and Recognition

His academic contributions are reflected in his publication record and research profiles. Shriyansh Srivastava is actively engaged in scholarly activities, evidenced by his presence on Google Scholar, ResearchGate, Orchid, and Scopus. These platforms highlight his commitment to disseminating research and contributing to the academic community.

🌟 Impact and Influence

As a young academician, Shriyansh Srivastava’s influence extends beyond his teaching role. His research on cardiomyopathy and pharmacological interventions holds promise for advancing treatment options. By mentoring students and participating in academic forums, he continues to inspire future pharmacists and researchers.

🌍 Legacy and Future Contributions

Looking ahead, Shriyansh Srivastava aims to strengthen his technical competence and business acumen over the next three years, contributing to both academic growth and pharmaceutical innovation. His dedication to excellence in teaching and research ensures a lasting impact on the field of pharmacy.

📖Publications Top Noted:

Paper Title: Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer management

Authors: S Srivastava, N Jayaswal, S Kumar, PK Sharma, T Behl, A Khalid, …
Journal: Cellular Signalling
Volume: 113
Pages: 110932
Citations: 15
Year: 2024

Paper Title: Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation

Authors: S Dhoundiyal, S Srivastava, S Kumar, G Singh, S Ashique, R Pal, …
Journal: European Journal of Medical Research
Volume: 29
Issue: 1
Pages: 26
Citations: 12
Year: 2024

Paper Title: Emergence of Marburg virus: a global perspective on fatal outbreaks and clinical challenges

Authors: S Srivastava, D Sharma, S Kumar, A Sharma, R Rijal, A Asija, S Adhikari, …
Journal: Frontiers in Microbiology
Volume: 14
Pages: 1239079
Citations: 10
Year: 2023

Paper Title: The Global Monkeypox (Mpox) outbreak: a comprehensive review

Authors: S Srivastava, S Kumar, S Jain, A Mohanty, N Thapa, P Poudel, K Bhusal, …
Journal: Vaccines
Volume: 11
Issue: 6
Pages: 1093
Citations: 10
Year: 2023

Paper Title: Biodegradable electrospun scaffolds as an emerging tool for skin wound regeneration: A comprehensive review

Authors: D Sharma, S Srivastava, S Kumar, PK Sharma, R Hassani, HG Dailah, …
Journal: Pharmaceuticals
Volume: 16
Issue: 2
Pages: 325
Citations: 9
Year: 2023

Paper Title: Wnt/β-catenin antagonist pyrvinium rescues high dose isoproterenol induced cardiotoxicity in rats: Biochemical and immunohistological evidences

Authors: S Srivastava, S Yadav, G Singh, SS Bajwa
Journal: Chemico-Biological Interactions
Volume: 358
Pages: 109902
Citations: 8
Year: 2022

Paper Title: Platelet‐rich plasma exhibits anti‐inflammatory effect and attenuates cardiomyocyte damage by reducing NF‐κB and enhancing VEGF expression in isoproterenol induced …

Authors: S Yadav, S Srivastava, G Singh
Journal: Environmental Toxicology
Volume: 37
Issue: 4
Pages: 936-953
Citations: 5
Year: 2022

Paper Title: Evolution of β-catenin-independent Wnt–GSK3–mTOR signalling in regulation of energy metabolism in isoproterenol-induced cardiotoxicity model

Authors: S Srivastava, N Bagang, S Yadav, S Rajput, D Sharma, A Dahiya, …
Journal: Inflammation Research
Volume: 70
Issue: 7
Pages: 743-747
Citations: 5
Year: 2021

Paper Title: Recent Nipah virus outbreak in India: lessons and imperatives

Authors: S Srivastava, N Deb, P Roy, V Jaiswal, S Sah, Y Pandey, …
Journal: Therapeutic Advances in Infectious Disease
Volume: 10
Pages: 20499361231208535
Citations: 3
Year: 2023

Paper Title: Nipah virus strikes Kerala: recent cases and implications

Authors: S Srivastava, PK Sharma, S Gurjar, S Kumar, Y Pandey, S Rustagi, …
Journal: The Egyptian Journal of Internal Medicine
Volume: 36
Issue: 1
Pages: 11
Citations: 2
Year: 2024

SRM Institute of Science and Technology, India

Author Profile

Early Academic Pursuits

Dr. P.N. REMYA embarked on her academic journey with a Bachelor's degree in Pharmacy from S. Chattanatha Karayalar College of Pharmacy, followed by a Master's degree in Pharmaceutics from Arulmigu Kalasalingam College of Pharmacy. Her educational pursuit culminated in a Ph.D. from SRM Institute of Science and Technology, specializing in Pharmaceutics.

Professional Endeavors

Her professional trajectory spans a wealth of teaching experience, from a Tutor post-UG certification to Lecturer roles in various prestigious institutions. Notably, she has been an Associate Professor at SRM College of Pharmacy since October 2018, building upon four years as an Assistant Professor and seven years as a Lecturer in the same institution.

Contributions and Research Focus

Her contributions in academia are multifaceted. She has delved into diverse research projects ranging from sustained-release formulations to topical preparations and nanoparticles. Noteworthy projects include the development of sustained-release Aceclofenac matrix tablets, formulation of bi-layer tablets, and the ongoing research on solid lipid nanoparticles for poorly soluble antihypertensive drugs.

Accolades and Recognition

Her academic prowess is underscored by numerous presentations at national and international conferences, such as the Indian Pharmaceutical Congress and workshops on pharmaceutical technologies and clinical research methodologies. She has also published papers in reputable journals and presented posters on innovative drug delivery systems and formulation strategies.

Impact and Influence

Her impact extends beyond research and teaching. She has actively participated in workshops on quality improvement, pharmacokinetics, and regulatory perspectives, showcasing her commitment to staying abreast of industry trends and fostering a culture of excellence in pharmaceutical education.

Legacy and Future Contributions

As a seasoned educator and researcher, Her legacy lies in her dedication to nurturing future pharmacists and advancing pharmaceutical sciences through cutting-edge research. Her future contributions are poised to further enhance drug delivery systems, formulation technologies, and academic collaborations, ensuring a lasting impact on the field of pharmacy.

Notable Publications